| 101 |
19183127 | A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia. | 2009 Jun |
3 |
| 102 |
19188609 | Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. | 2009 Feb 10 |
2 |
| 103 |
19217454 | Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone. | 2009 Mar |
3 |
| 104 |
19283231 | Controversies in type 2 diabetes - An update. | 2009 Jan-Feb |
1 |
| 105 |
19322744 | The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART). | 2009 Jul |
2 |
| 106 |
19338578 | Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs. | 2009 Jul |
5 |
| 107 |
19368716 | Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. | 2009 Apr 15 |
2 |
| 108 |
19405411 | Drug treatments for polycystic ovary syndrome. | 2009 Apr 15 |
1 |
| 109 |
19449752 | [Drugs influencing bone metabolism in diabetic patients]. | 2009 Apr |
1 |
| 110 |
19449763 | [Insulin sensitizing drugs]. | 2009 Apr |
1 |
| 111 |
19475776 | Safety and efficacy of rosiglitazone in the elderly diabetic patient. | 2009 |
1 |
| 112 |
19533082 | Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1. | 2009 Sep |
1 |
| 113 |
19776322 | Rosiglitazone effects to ameliorate Alzheimer's disease pathogenic features: insulin signaling and neurotrophic factors. | 2009 Summer |
1 |
| 114 |
19821299 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | 2009 Oct 7 |
1 |
| 115 |
19839823 | Effects of rosiglitazone on cardiac function in CAPD patients: a tissue Doppler study. | 2009 |
2 |
| 116 |
21299185 | Adverse effect of pioglitazone in military personnel and their families: a preliminary report. | 2009 Feb |
1 |
| 117 |
24683246 | Effectiveness and tolerability of rosiglitazone on insulin resistance and body composition in nondiabetic Thai patients undergoing continuous ambulatory peritoneal dialysis: A 12-week pilot study. | 2009 Oct |
3 |
| 118 |
17394563 | Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients. | 2008 Jun |
4 |
| 119 |
17825080 | Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents. | 2008 Sep |
1 |
| 120 |
17956948 | Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses. | 2008 Jan |
4 |
| 121 |
18054196 | Insulin regulates the expression of adiponectin and adiponectin receptors in porcine adipocytes. | 2008 May |
3 |
| 122 |
18095238 | Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone. | 2008 Jan |
1 |
| 123 |
18191635 | Rosiglitazone stimulates the release and synthesis of insulin by enhancing GLUT-2, glucokinase and BETA2/NeuroD expression. | 2008 Mar 14 |
2 |
| 124 |
18212130 | Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. | 2008 Jan 29 |
1 |
| 125 |
18215356 | Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients. | 2008 Feb |
1 |
| 126 |
18220486 | Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes. | 2008 Feb |
1 |
| 127 |
18254722 | Importance of the high-molecular-mass isoform of adiponectin in improved insulin sensitivity with rosiglitazone treatment in HIV disease. | 2008 Sep |
5 |
| 128 |
18285418 | Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production. | 2008 May |
3 |
| 129 |
18322300 | Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. | 2008 Jun |
1 |
| 130 |
18328348 | Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients. | 2008 Apr |
3 |
| 131 |
18332304 | Low-dose rosiglitazone in patients with type 2 diabetes mellitus requiring insulin therapy. | 2008 Mar 10 |
1 |
| 132 |
18346728 | A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects. | 2008 Apr 14 |
2 |
| 133 |
18375253 | Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin. | 2008 May |
1 |
| 134 |
18394743 | Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus. | 2008 Jul |
2 |
| 135 |
18460571 | The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function. | 2008 Jul |
4 |
| 136 |
18466213 | The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycaemic control: a randomized-controlled trial. | 2008 Jul 28 |
2 |
| 137 |
18476983 | Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients. | 2008 Dec |
2 |
| 138 |
18492785 | Treatment options in insulin resistance obesity-related acanthosis nigricans. | 2008 Jul |
1 |
| 139 |
18541328 | The effect of rosiglitazone on oxidative stress and insulin resistance in overweight individuals. | 2008 Aug |
4 |
| 140 |
18572037 | Comparison of three treatment approaches to decreasing cardiovascular disease risk in nondiabetic insulin-resistant dyslipidemic subjects. | 2008 Jul 1 |
3 |
| 141 |
18583261 | [Effects of rosiglitazone on inflammatory reaction and insulin resistance in obese patients with newly diagnosed type 2 diabetes]. | 2008 Jun |
3 |
| 142 |
18812026 | Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. | 2008 Oct |
1 |
| 143 |
19011089 | A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. | 2008 Nov 25 |
1 |
| 144 |
19033001 | Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics. | 2008 Dec |
2 |
| 145 |
19075761 | Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress. | 2008 |
1 |
| 146 |
19097138 | Evaluation of rosiglitazone administration on cardiovascular function in severe obesity. | 2008 Dec |
1 |
| 147 |
21221185 | Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy. | 2008 Feb 29 |
1 |
| 148 |
30764090 | Role of retinol-binding protein 4 in the pathogenesis of Type 2 diabetes. | 2008 Mar |
1 |
| 149 |
17040956 | Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. | 2007 Jan |
1 |
| 150 |
17090751 | Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. | 2007 Mar |
2 |